Used for treating certain cancers of the blood, including chronic myelomonocytic leukemia. Azacitidine is an antineoplastic. It works by causing the death of abnormal, rapidly dividing cells in the bone marrow.
Related categories 1
Sites 3
- Vidaza.com Patient information about the first drug approved for treatment of myelodysplastic syndromes. Manufacturer presents treatment, drug and disease information.
- DrugBank: Azacitidine Full chemical and drug information. Includes indication, pharmacology and contraindications.
- MedlinePlus: Azacitidine (Injection) Features information about dosage, usage, warnings, and side effects.